Home›Companies›Healthcare›Xenon Ophthalmics

Xenon Ophthalmics Inc

Eye care systems for practices, from scheduling appointments to finishing eyewear.

Updated Nov 9, 2026·Latest SEC filing Oct 6, 2026·Suggest an edit

About Xenon Ophthalmics

Xenon Ophthalmics is a private company based in Jersey City, New Jersey. It has reported $3,315,004 raised in one offering on Form D since August 2023. Its chief executive is Zeshan Khan.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 15, 2019Aug 22, 2023amended Oct 6, 2026$3,315,004target not set20$165KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Xenon Ophthalmics's Form D filed Oct 6, 2026.

Zeshan Khan
Zeshan Khan
Founder and CEO, director
Steve Susanibar
Steve Susanibar
Co-Founder, Product Director
Robert Gilligan
Robert Gilligan
Co-Founder, Medical Relations, Board of Directors
David Singelyn
David Singelyn
Board of Directors

Sources

  1. SECXenon Ophthalmics Inc Form D/A, filed Aug 22, 2023
  2. SECXenon Ophthalmics Inc Form D, filed Aug 22, 2023
  3. SECXenon Ophthalmics Inc filing history
  4. CompanyAbout Xenon Ophthalmics
  5. CompanyXenon Ophthalmics team